Industry: Service & Software
Published Date: 2024-11-12
Pages: 108 Pages
Report ld: 3372234
Request Sample
Customized Report
AI Drug Discovery Software Market Size(US$)

CAGR 2024-2030
14%
Market Size,2030
USD 1,119
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global AI Drug Discovery Software revenue was US$ 470 million in 2023 and is forecast to a readjusted size of US$ 1119 million by 2030 with a CAGR of 14.0% during the review period (2024-2030).
In United States the AI Drug Discovery Software revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States AI Drug Discovery Software market, also covers the segmentation data of other regions in regional level and county level.
AI drug discovery software is a software tool that accelerates the drug development process by utilizing artificial intelligence algorithms and technologies. This software integrates and analyzes a vast amount of bioinformatics data, chemical structure data, and clinical trial data to predict key properties such as compound bioactivity, pharmacokinetic characteristics, and toxicity. With the help of AI technology, drug researchers can more quickly and accurately screen potential candidate drugs, thereby reducing development costs, shortening development cycles, and improving success rates.
The global key players of AI Drug Discovery Software include Nanolive, TandemAI, Benevolent, Atomwise, Cradle, Exscientia, Iktos, Insilico Medicine, Collaborative Drug Discovery, Valence Labs, etc. The global five biggest players hold a share of % in 2023.
Global AI Drug Discovery Software Scope and Market Size
AI Drug Discovery Software market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global AI Drug Discovery Software market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the AI Drug Discovery Software market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces AI Drug Discovery Software definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of AI Drug Discovery Software companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of AI Drug Discovery Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Discovery Software revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 AI Drug Discovery Software Product Introduction
1.2 Global AI Drug Discovery Software Outlook, 2019 VS 2023 VS 2030
1.2.1 Global AI Drug Discovery Software Market Size for the Year 2019-2030
1.2.2 United States AI Drug Discovery Software Market Size for the Year 2019-2030
1.3 AI Drug Discovery Software Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.3.1 The Market Share of United States AI Drug Discovery Software in Global, 2019 VS 2023 VS 2030
1.3.2 The Growth Rate of AI Drug Discovery Software Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4 AI Drug Discovery Software Market Dynamics
1.4.1 AI Drug Discovery Software Industry Trends
1.4.2 AI Drug Discovery Software Market Drivers
1.4.3 AI Drug Discovery Software Market Challenges
1.4.4 AI Drug Discovery Software Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 AI Drug Discovery Software by Type
2.1 AI Drug Discovery Software Market by Type
2.1.1 Cloud Based
2.1.2 On Premise
2.2 Global AI Drug Discovery Software Market Size by Type (2019, 2023 & 2030)
2.3 Global AI Drug Discovery Software Market Size by Type (2019-2030)
2.4 United States AI Drug Discovery Software Market Size by Type (2019, 2023 & 2030)
2.5 United States AI Drug Discovery Software Market Size by Type (2019-2030)
3 AI Drug Discovery Software by Application
3.1 AI Drug Discovery Software Market by Application
3.1.1 CRO and Universities
3.1.2 Pharmaceutical Company
3.1.3 Test Lab
3.2 Global AI Drug Discovery Software Market Size, by Application (2019, 2023 & 2030)
3.3 Global AI Drug Discovery Software Market Size by Application (2019-2030)
3.4 United States AI Drug Discovery Software Market Size by Application (2019, 2023 & 2030)
3.5 United States AI Drug Discovery Software Market Size by Application (2019-2030)
4 Global AI Drug Discovery Software Competitor Landscape by Company
4.1 Global AI Drug Discovery Software Market Size by Company
4.1.1 Global Key Companies of AI Drug Discovery Software, Ranked by Revenue (2023)
4.1.2 Global AI Drug Discovery Software Revenue by Player (2019-2024)
4.2 Global AI Drug Discovery Software Concentration Ratio (CR)
4.2.1 AI Drug Discovery Software Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of AI Drug Discovery Software in 2023
4.2.3 Global AI Drug Discovery Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of AI Drug Discovery Software Head office and Area Served
4.4 Global Key Players of AI Drug Discovery Software, Product and Application
4.5 Global Key Players of AI Drug Discovery Software, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States AI Drug Discovery Software Market Size by Company
4.7.1 Key Players of AI Drug Discovery Software in United States, Ranked by Revenue (2023)
4.7.2 United States AI Drug Discovery Software Revenue by Players (2022, 2023 & 2024)
5 Global AI Drug Discovery Software Market Size by Region
5.1 Global AI Drug Discovery Software Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global AI Drug Discovery Software Market Size by Region (2019-2030)
5.2.1 Global AI Drug Discovery Software Market Size by Region: 2019-2024
5.2.2 Global AI Drug Discovery Software Market Size by Region: 2025-2030
6 Americas
6.1 Americas AI Drug Discovery Software Market Size YoY Growth 2019-2030
6.2 Americas AI Drug Discovery Software Market Size by Type
6.2.1 Americas AI Drug Discovery Software Market Size by Type (2019-2024)
6.2.2 Americas AI Drug Discovery Software Market Size by Type (2025-2030)
6.2.3 Americas AI Drug Discovery Software Market Share by Type (2019-2030)
6.3 Americas AI Drug Discovery Software Market Size by Application
6.3.1 Americas AI Drug Discovery Software Market Size by Application (2019-2024)
6.3.2 Americas AI Drug Discovery Software Market Size by Application (2025-2030)
6.3.3 Americas AI Drug Discovery Software Market Share by Application (2019-2030)
6.4 Americas AI Drug Discovery Software Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA AI Drug Discovery Software Market Size YoY Growth 2019-2030
7.2 EMEA AI Drug Discovery Software Market Size by Type
7.2.1 EMEA AI Drug Discovery Software Market Size by Type (2019-2024)
7.2.2 EMEA AI Drug Discovery Software Market Size by Type (2025-2030)
7.2.3 EMEA AI Drug Discovery Software Market Share by Type (2019-2030)
7.3 EMEA AI Drug Discovery Software Market Size by Application
7.3.1 EMEA AI Drug Discovery Software Market Size by Application (2019-2024)
7.3.2 EMEA AI Drug Discovery Software Market Size by Application (2025-2030)
7.3.3 EMEA AI Drug Discovery Software Market Share by Application (2019-2030)
7.4 EMEA AI Drug Discovery Software Market Facts & Figures by Region (2019, 2023 & 2030)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China AI Drug Discovery Software Market Size by Type
8.1.1 China AI Drug Discovery Software Market Size by Type (2019-2024)
8.1.2 China AI Drug Discovery Software Market Size by Type (2025-2030)
8.1.3 China AI Drug Discovery Software Market Share by Type (2019-2030)
8.2 China AI Drug Discovery Software Market Size by Application
8.2.1 China AI Drug Discovery Software Market Size by Application (2019-2024)
8.2.2 China AI Drug Discovery Software Market Size by Application (2025-2030)
8.2.3 China AI Drug Discovery Software Market Share by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC AI Drug Discovery Software Market Size YoY Growth 2019-2030
9.2 APAC AI Drug Discovery Software Market Size by Type
9.2.1 APAC AI Drug Discovery Software Market Size by Type (2019-2024)
9.2.2 APAC AI Drug Discovery Software Market Size by Type (2025-2030)
9.2.3 APAC AI Drug Discovery Software Market Share by Type (2019-2030)
9.3 APAC AI Drug Discovery Software Market Size by Application
9.3.1 APAC AI Drug Discovery Software Market Size by Application (2019-2024)
9.3.2 APAC AI Drug Discovery Software Market Size by Application (2025-2030)
9.3.3 APAC AI Drug Discovery Software Market Share by Application (2019-2030)
9.4 APAC AI Drug Discovery Software Market Facts & Figures by Region (2019, 2023 & 2030)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 ASEAN
9.4.5 India
10 Key Players Profiles
10.1 Nanolive
10.1.1 Nanolive Company Details
10.1.2 Nanolive Business Overview
10.1.3 Nanolive AI Drug Discovery Software Introduction
10.1.4 Nanolive Revenue in AI Drug Discovery Software Business (2019-2024)
10.1.5 Nanolive Recent Development
10.2 TandemAI
10.2.1 TandemAI Company Details
10.2.2 TandemAI Business Overview
10.2.3 TandemAI AI Drug Discovery Software Introduction
10.2.4 TandemAI Revenue in AI Drug Discovery Software Business (2019-2024)
10.2.5 TandemAI Recent Development
10.3 Benevolent
10.3.1 Benevolent Company Details
10.3.2 Benevolent Business Overview
10.3.3 Benevolent AI Drug Discovery Software Introduction
10.3.4 Benevolent Revenue in AI Drug Discovery Software Business (2019-2024)
10.3.5 Benevolent Recent Development
10.4 Atomwise
10.4.1 Atomwise Company Details
10.4.2 Atomwise Business Overview
10.4.3 Atomwise AI Drug Discovery Software Introduction
10.4.4 Atomwise Revenue in AI Drug Discovery Software Business (2019-2024)
10.4.5 Atomwise Recent Development
10.5 Cradle
10.5.1 Cradle Company Details
10.5.2 Cradle Business Overview
10.5.3 Cradle AI Drug Discovery Software Introduction
10.5.4 Cradle Revenue in AI Drug Discovery Software Business (2019-2024)
10.5.5 Cradle Recent Development
10.6 Exscientia
10.6.1 Exscientia Company Details
10.6.2 Exscientia Business Overview
10.6.3 Exscientia AI Drug Discovery Software Introduction
10.6.4 Exscientia Revenue in AI Drug Discovery Software Business (2019-2024)
10.6.5 Exscientia Recent Development
10.7 Iktos
10.7.1 Iktos Company Details
10.7.2 Iktos Business Overview
10.7.3 Iktos AI Drug Discovery Software Introduction
10.7.4 Iktos Revenue in AI Drug Discovery Software Business (2019-2024)
10.7.5 Iktos Recent Development
10.8 Insilico Medicine
10.8.1 Insilico Medicine Company Details
10.8.2 Insilico Medicine Business Overview
10.8.3 Insilico Medicine AI Drug Discovery Software Introduction
10.8.4 Insilico Medicine Revenue in AI Drug Discovery Software Business (2019-2024)
10.8.5 Insilico Medicine Recent Development
10.9 Collaborative Drug Discovery
10.9.1 Collaborative Drug Discovery Company Details
10.9.2 Collaborative Drug Discovery Business Overview
10.9.3 Collaborative Drug Discovery AI Drug Discovery Software Introduction
10.9.4 Collaborative Drug Discovery Revenue in AI Drug Discovery Software Business (2019-2024)
10.9.5 Collaborative Drug Discovery Recent Development
10.10 Valence Labs
10.10.1 Valence Labs Company Details
10.10.2 Valence Labs Business Overview
10.10.3 Valence Labs AI Drug Discovery Software Introduction
10.10.4 Valence Labs Revenue in AI Drug Discovery Software Business (2019-2024)
10.10.5 Valence Labs Recent Development
10.11 Certara
10.11.1 Certara Company Details
10.11.2 Certara Business Overview
10.11.3 Certara AI Drug Discovery Software Introduction
10.11.4 Certara Revenue in AI Drug Discovery Software Business (2019-2024)
10.11.5 Certara Recent Development
10.12 Insilico
10.12.1 Insilico Company Details
10.12.2 Insilico Business Overview
10.12.3 Insilico AI Drug Discovery Software Introduction
10.12.4 Insilico Revenue in AI Drug Discovery Software Business (2019-2024)
10.12.5 Insilico Recent Development
10.13 Genentech
10.13.1 Genentech Company Details
10.13.2 Genentech Business Overview
10.13.3 Genentech AI Drug Discovery Software Introduction
10.13.4 Genentech Revenue in AI Drug Discovery Software Business (2019-2024)
10.13.5 Genentech Recent Development
10.14 Merck
10.14.1 Merck Company Details
10.14.2 Merck Business Overview
10.14.3 Merck AI Drug Discovery Software Introduction
10.14.4 Merck Revenue in AI Drug Discovery Software Business (2019-2024)
10.14.5 Merck Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global AI Drug Discovery Software market is projected to grow from US$ 862 million in 2025 to US$ 2429 million by 2032, at a CAGR of 15.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 137
USD 4900.00
(Single User License)
The global AI Drug Discovery Software market size was US$ 862 million in 2025 and is forecast to reach a readjusted size of US$ 2429 million by 2032 with a CAGR of 15.7% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 99
USD 4250.00
(Single User License)
The global AI Drug Discovery Software market was valued at US$ 862 million in 2025 and is anticipated to reach US$ 2429 million by 2032, at a CAGR of 15.7% from 2026 to 2032.
Published Date: 2026-01-20
Pages: 111
USD 2900.00
(Single User License)
The global market for AI Drug Discovery Software was estimated to be worth US$ 862 million in 2025 and is projected to reach US$ 2429 million, growing at a CAGR of 15.7% from 2026 to 2032.
Published Date: 2026-01-20
Pages: 111
USD 3950.00
(Single User License)
The global AI Drug Discovery Software market size was US$ 510 million in 2024 and is forecast to a readjusted size of US$ 1260 million by 2031 with a CAGR of 14.0% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 93
USD 4250.00
(Single User License)
The global AI Drug Discovery Software market is projected to grow from US$ 510 million in 2024 to US$ 1260 million by 2031, at a CAGR of 14.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 139
USD 4900.00
(Single User License)
The global market for AI Drug Discovery Software was estimated to be worth US$ 510 million in 2024 and is forecast to a readjusted size of US$ 1260 million by 2031 with a CAGR of 14.0% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 111
USD 3950.00
(Single User License)
The global market for AI Drug Discovery Software was valued at US$ 510 million in the year 2024 and is projected to reach a revised size of US$ 1260 million by 2031, growing at a CAGR of 14.0% during the forecast period.
Published Date: 2025-03-12
Pages: 81
USD 2900.00
(Single User License)
The global AI Drug Discovery Software market is projected to grow from US$ 510 million in 2024 to US$ 1119 million by 2030, at a Compound Annual Growth Rate (CAGR) of 14.0% during the forecast period.
Published Date: 2024-11-12
Pages: 138
USD 4900.00
(Single User License)
The global market for AI Drug Discovery Software was estimated to be worth US$ 470 million in 2023 and is forecast to a readjusted size of US$ 1119 million by 2030 with a CAGR of 14.0% during the forecast period 2024-2030.
Published Date: 2024-11-12
Pages: 119
USD 3950.00
(Single User License)
The global AI Drug Discovery Software market is projected to grow from US$ 862 million in 2025 to US$ 2429 million by 2032, at a CAGR of 15.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 137
The global AI Drug Discovery Software market size was US$ 862 million in 2025 and is forecast to reach a readjusted size of US$ 2429 million by 2032 with a CAGR of 15.7% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 99
The global AI Drug Discovery Software market was valued at US$ 862 million in 2025 and is anticipated to reach US$ 2429 million by 2032, at a CAGR of 15.7% from 2026 to 2032.
Published: 2026-01-20
Pages: 111
The global market for AI Drug Discovery Software was estimated to be worth US$ 862 million in 2025 and is projected to reach US$ 2429 million, growing at a CAGR of 15.7% from 2026 to 2032.
Published: 2026-01-20
Pages: 111
The global AI Drug Discovery Software market size was US$ 510 million in 2024 and is forecast to a readjusted size of US$ 1260 million by 2031 with a CAGR of 14.0% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 93
The global AI Drug Discovery Software market is projected to grow from US$ 510 million in 2024 to US$ 1260 million by 2031, at a CAGR of 14.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 139
The global market for AI Drug Discovery Software was estimated to be worth US$ 510 million in 2024 and is forecast to a readjusted size of US$ 1260 million by 2031 with a CAGR of 14.0% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 111
The global market for AI Drug Discovery Software was valued at US$ 510 million in the year 2024 and is projected to reach a revised size of US$ 1260 million by 2031, growing at a CAGR of 14.0% during the forecast period.
Published: 2025-03-12
Pages: 81
The global AI Drug Discovery Software market is projected to grow from US$ 510 million in 2024 to US$ 1119 million by 2030, at a Compound Annual Growth Rate (CAGR) of 14.0% during the forecast period.
Published: 2024-11-12
Pages: 138
The global market for AI Drug Discovery Software was estimated to be worth US$ 470 million in 2023 and is forecast to a readjusted size of US$ 1119 million by 2030 with a CAGR of 14.0% during the forecast period 2024-2030.
Published: 2024-11-12
Pages: 119
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now